查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827770

2025年全球整形外科重建产品市场报告

Orthopedic Regenerative Surgical Products Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，整形外科重建产品市场呈现强劲成长势头，市场规模从2024年的45.4亿美元增至2025年的48.8亿美元，复合年增长率达7.5%。预测期内的成长主要受人口老化、整形外科损伤、病患需求、运动医学和肌肉骨骼疾病等因素所驱动。

预计未来几年整形外科​​重建手术产品市场规模将强劲成长，到2029年将达到68.4亿美元，复合年增长率为8.8%。预测期内的成长归因于监管核准、永续实践、微创手术、復健和物理治疗以及关节保护。预测期内的主要趋势包括先进的生物材料、外科手术的进步、人工智慧 (AI) 和预测分析、再生医学的进步以及整形外科植入。

整形外科骨科产品在治疗各种肌肉骨骼疾病方面发挥重要作用，包括关节痛、痛风、关节缺损、纤维肌痛、骨关节炎、创伤、关节重建和其他整形外科损伤。这些产品在再生整形外科医学中尤其重要，其中富血小板血浆 (PRP) 等非手术治疗通常用于辅助癒合和修復影响关节、肌腱、韧带和肌肉的肌肉骨骼损伤。

整形外科再生手术产品的主要类型包括同种异体移植、合成材料、细胞产品和黏性补充。同种异体移植是指在同一物种的不同基因个体之间进行组织移植。人体同种异体移植的例子包括胫骨前肌腱、冷冻股骨头、冷冻干燥骨碎片、脱矿骨基质 (DBM) 腻子、去细胞真皮和羊膜。这些再生产品在医院、门诊手术中心和其他医疗机构用于治疗整形外科疾病，包括疼痛管理、创伤修復、软骨和肌腱修復以及关节重组。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供整形外科重建产品市场统计数据，包括全球市场规模、区域份额、整形外科重建产品市场份额竞争对手、详细的整形外科重建产品细分市场、市场趋势和商业机会，以及在整形外科重建产品整形外科取得成功所需的数据。本整形外科重建产品市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年8.8%的预测成长率，较我们先前对该市场的预测略有下降0.1%。下降主要源自于美国与其他国家之间关税的影响。这种影响将透过对主要来自韩国和瑞士的生物工程组织和生长因子征收关税直接影响美国，这可能会增加先进软骨修復和骨再生手术的成本。由于互惠关税以及贸易紧张局势和限制措施升级对全球经济和贸易的负面影响，这种影响也将更加广泛。

全球整形外科疾病盛行率的不断上升预计将推动整形外科再生产品市场的成长。这些产品有助于预防骨折、扭伤和拉伤等整形外科问题，并管理导致功能受限和残疾的终身疾病。例如，澳洲统计局2024年6月的报告显示，到2023年，肌肉骨骼疾病将占总疾病负担（DALY）的12.8%，占非致命性年度死亡人数（YLD）的23.1%，占致命性年度死亡人数（YLL）的0.8%。到2022年，这些疾病将成为10,446例死亡（每10万人口中有40例）的潜在或相关原因，占所有死亡人数的5.5%。因此，整形外科疾病发生率的不断上升正在推动对整形外科再生产品的需求。

预计整形外科重建产品市场的成长将由医院数量的增加所推动。作为医疗机构，医院在为病人和伤者提供治疗、护理和服务方面至关重要。医院采用整形外科重建产品可以改善患者预后、降低併发症风险、加速癒合和康復，并提供先进的重建手术选择。截至 2023 年 5 月，美国医院协会 (AHA) 报告称，医院总数从 2022 年的 6,093 家增加到 6,129 家，所有美国医院的住院总人数达到 34,011,386 人次，高于上一年的 33,356,853 人次。因此，医院数量的增加是推动整形外科重建产品市场扩张的关键因素。

技术进步已成为整形外科再生手术产品市场的关键趋势。例如，2022年5月，美国生物製药公司Ocugen Inc.宣布推出NeoCart，这是一项处于3期临床阶段的细胞治疗平台技术（自体软骨细胞衍生的新生软骨）。 NeoCart最近获得了美国食品药物管理局（FDA）颁发的再生医学先进疗法（RMAT）认证，用于治疗成人膝关节软骨全层病变。

为了推动市场收益，整形外科重建手术市场的主要企业正策略性地专注于非永久性骨纤维压缩钉等创新产品。这些医疗设备用于整形外科和肌肉骨骼手术中的骨折固定和骨癒合，提供临时稳定性和压迫以支持癒合和融合。例如，专门从事整形外科和肌肉骨骼应用的美国公司 Ossiofiber Inc. 于 2023 年 2 月推出了非永久性 Ossiofiber 压缩钉。这种钉子结合了机械强度和自发性骨再生能力，为传统植入（如可吸收或同种异体植入物和永久性金属硬体）提供了替代方案。 Ossiofiber 压缩钉为各种中足和后足手术提供解决方案，包括扁平足矫正术、Lapidus 固定和中足融合。

2022年4月，专注于骨生物技术和细胞疗法的美国公司Isto Biologics收购了TheraCell，收购金额未揭露。此次收购旨在增强Isto Biologics在脊椎、整形外科和运动医学领域的外科和临床护理解决方案组合。 TheraCell是一家美国再生医学公司，专注于开发用于骨骼修復和组织再生的创新产品。

整形外科再生手术产品市场的主要企业包括 Baxter International Inc.、Zimmer Biomet Holdings Inc.、Stryker Corporation、Smith & Nephew plc、Allosource、Anika Therapeutics Inc.、Vericel Corporation、Amniox Medical Inc.、MIMEDX Group Inc.、Aptissen SA、Art； LifeSciences Corporation、Johnson & Johnson Medical Devices group、Kuros Biosciences AG、Medtronic plc、NuVasive Inc.、Orthofix Medical Inc.、Osiris Therapeutics Inc.、RTI Surgical Inc.、SeaSpine Holdings Corporation、Terumo BCT Inc.、Tissue Rerights Inc.t. Spine Inc.、CollPlant Biotechnologies Ltd.等。

预计到2024年，北美将成为整形外科重建产品市场最大的地区，并有望成为预测期内成长最快的地区。整形外科重建产品市场分析报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

整形外科重建手术产品市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。

整形外科重建产品市场包括同种异体骨楔、allowrap DS、BIO4、DBM、水凝固剂、吸收剂、神经修復和软骨再生 (prochondrix CR)。该市场的价值是指“出厂价”，即产品製造商或创造者销售给其他营业单位（包括下游製造商、经销商、分销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球整形外科重建外科产品：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球整形外科重建产品市场：成长率分析
  • 全球整形外科重建产品市场表现：规模与成长，2019-2024
  • 全球整形外科重建产品市场预测：规模与成长，2024-2029年，2034年
  • 全球整形外科重建产品：总目标市场（TAM）

第六章 市场细分

  • 全球整形外科重建手术产品市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 同种异体移植
  • 合成
  • 基于细胞
  • 黏稠补充剂
  • 全球整形外科重建产品市场：依应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 整形外科疼痛管理
  • 创伤修復
  • 软骨和肌腱修復
  • 关节重组
  • 全球整形外科重建产品市场（按最终用户、业绩和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 门诊手术中心
  • 其他最终用户
  • 全球整形外科重建产品市场：按同种异体移植、类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 同种异体骨移植
  • 软组织同种异体移植
  • 骨诱导同种异体移植
  • 骨传导同种异体移植
  • 全球整形外科重建产品市场：按类型、成长和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 合成骨移植
  • 合成软组织移植
  • 复合合成移植物
  • 全球整形外科再生医学产品市场​​：按细胞类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 干细胞疗法
  • 富血小板血浆（PRP）
  • 间质干细胞（MSCs）
  • 全球整形外科重建产品市场：黏性补充剂细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 玻尿酸注射
  • 透明质酸钠
  • 其他浓稠补充剂产品

第七章 区域和国家分析

  • 全球整形外科重建产品市场：区域表现及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 全球整形外科重建产品市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 整形外科再生手术产品市场：竞争格局
  • 整形外科重建产品市场：公司简介
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Smith & Nephew plc Overview, Products and Services, Strategy and Financial Analysis
    • Allosource Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Anika Therapeutics Inc.
  • Vericel Corporation
  • Amniox Medical Inc.
  • MIMEDX Group Inc.
  • Aptissen SA
  • Arthrex Inc.
  • Bioventus LLC
  • Conmed Corporation
  • DePuy Synthes Inc.
  • Exactech Inc.
  • Globus Medical Inc.
  • Integra LifeSciences Corporation
  • Johnson & Johnson Medical Devices group
  • Kuros Biosciences AG
  • Medtronic plc

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年整形外科重建产品市场：提供新机会的国家
  • 2029 年整形外科重建产品市场：细分市场将带来新机会
  • 2029 年整形外科重建产品市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r21893u

Orthopedic regenerative surgical products play a crucial role in treating various musculoskeletal conditions, including joint pains, gout, articular defects, fibromyalgia, osteoarthritis, trauma, joint replacement, and other orthopedic injuries. These products are particularly significant in regenerative orthopedic medicine, where nonsurgical treatments like platelet-rich plasma (PRP) are often chosen to aid in the healing and repair of musculoskeletal injuries, such as those affecting joints, tendons, ligaments, and muscles.

The main types of orthopedic regenerative surgical products include allografts, synthetic materials, cell-based products, and viscosupplements. Allografts involve the transplantation of tissue between genetically distinct individuals of the same species. Examples of human allografts include anterior tibialis tendon, frozen femoral head, freeze-dried bone chips, demineralized bone matrix (DBM) putty, acellular dermis, and amniotic membrane. These regenerative products are utilized by hospitals, ambulatory surgical centers, and other healthcare facilities for the treatment of orthopedic conditions such as pain management, trauma repair, cartilage and tendon repair, and joint reconstruction.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The orthopedic regenerative surgical products market research report is one of a series of new reports from The Business Research Company that provides orthopedic regenerative surgical products market statistics, including orthopedic regenerative surgical products industry global market size, regional shares, competitors with an orthopedic regenerative surgical products market share, detailed orthopedic regenerative surgical products market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic regenerative surgical products industry. This orthopedic regenerative surgical products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The orthopedic regenerative surgical products market size has grown strongly in recent years. It will grow from $4.54 billion in 2024 to $4.88 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to aging population, orthopedic injuries, patient demand, sports medicine, musculoskeletal disorders.

The orthopedic regenerative surgical products market size is expected to see strong growth in the next few years. It will grow to $6.84 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to regulatory approval, sustainable practices, minimally invasive procedures, rehabilitation and physicalTherapy, joint preservation. Major trends in the forecast period include advanced biomaterials, surgical advancements, artificial intelligence (ai) and predictive analytics, regenerative medicine advancements, orthopedic implants.

The forecast of 8.8% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on bioengineered tissues and growth factors, largely sourced from South Korea and Switzerland, raising expenses for advanced cartilage repair and bone regeneration procedures.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of orthopedic diseases worldwide is expected to drive the growth of the orthopedic regenerative surgical products market. These products help prevent orthopedic issues such as fractures, sprains, and strains, as well as manage lifelong conditions that cause functional limitations and disabilities. For example, in June 2024, a report by the Australian Bureau of Statistics, an Australia-based statistical agency, revealed that musculoskeletal conditions accounted for 12.8% of the total disease burden (DALY), 23.1% of the non-fatal burden (YLD), and 0.8% of the fatal burden (YLL) in 2023. In 2022, these conditions were the underlying or associated cause of 10,446 deaths (40 per 100,000 population), representing 5.5% of all deaths. Therefore, the rising incidence of orthopedic diseases is driving the demand for orthopedic regenerative surgical products.

The anticipated growth of the orthopedic regenerative surgical products market is expected to be propelled by the increasing number of hospitals. Hospitals, as healthcare institutions, are essential in providing medical treatment, care, and services to individuals who are ill or injured. The adoption of orthopedic regenerative surgical products in hospitals is associated with enhanced patient outcomes, reduced risk of complications, faster healing and recovery, and the availability of advanced regenerative surgical options. As of May 2023, the American Hospital Association (AHA) reported an increase in the total number of hospitals to 6,129 compared to 6,093 in 2022, with total admissions across all U.S. hospitals reaching 34,011,386 compared to 33,356,853 in the previous year. Therefore, the growing number of hospitals is a significant factor driving the expansion of the orthopedic regenerative surgical products market.

Technological advancements are emerging as a key trend in the orthopedic regenerative surgical products market. For example, in May 2022, Ocugen Inc., a U.S.-based biopharmaceutical company, introduced NeoCart, a Phase 3 cell therapy platform technology (autologous chondrocyte-derived neocartilage). NeoCart recently received Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for the treatment of full-thickness lesions in adult knee cartilage.

Major companies in the orthopedic regenerative surgical products market are strategically focusing on innovative products like the non-permanent ossiofiber compression staple to drive market revenues. This medical device is utilized in orthopedic and musculoskeletal surgeries for fracture fixation and bone fusion, providing temporary stability and compression to support healing and fusion. For instance, Ossio Inc., a US-based company specializing in orthopedic and musculoskeletal applications, launched the non-permanent ossiofiber compression staple in February 2023. Combining mechanical strength and spontaneous bone regeneration, this staple offers an alternative to traditional implants, such as resorbable and allograft options, as well as permanent metal hardware. Ossiofiber Compression Staples provide solutions for various midfoot and hindfoot procedures, including flatfoot corrective procedures, Lapidus fusions, and midfoot fusions.

In April 2022, Isto Biologics, a US-based company specializing in osteobiologic regeneration technologies and cell-based therapeutics, acquired TheraCell Inc. for an undisclosed sum. The acquisition aims to strengthen Isto Biologics' portfolio of surgical and clinical care solutions in the areas of spine, orthopedics, and sports medicine. TheraCell, Inc., a U.S.-based regenerative medicine company, focuses on developing innovative products for bone repair and tissue regeneration.

Major companies operating in the orthopedic regenerative surgical products market include Baxter International Inc., Zimmer Biomet Holdings Inc., Stryker Corporation, Smith&Nephew plc, Allosource, Anika Therapeutics Inc., Vericel Corporation, Amniox Medical Inc., MIMEDX Group Inc., Aptissen S.A, Arthrex Inc., Bioventus LLC, Conmed Corporation, DePuy Synthes Inc., Exactech Inc., Globus Medical Inc., Integra LifeSciences Corporation, Johnson & Johnson Medical Devices group, Kuros Biosciences AG, Medtronic plc, NuVasive Inc., Orthofix Medical Inc., Osiris Therapeutics Inc., RTI Surgical Inc., SeaSpine Holdings Corporation, Terumo BCT Inc., Tissue Regenix Group plc, Wright Medical Group N.V., Xtant Medical Holdings Inc., Camber Spine Technologies, Lima Corporate, Life Spine Inc., CollPlant Biotechnologies Ltd.

North America was the largest region in the orthopedic regenerative surgical products market in 2024 and is also expected to be the fastest-growing region in the forecast period. The regions covered in orthopedic regenerative surgical products market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the orthopedic regenerative surgical products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The orthopedic regenerative surgical products market consists of sales of allograft wedges, allowrap DS, BIO4, DBM, hydroset, imbibe, nerve repair, and prochondrix CR.Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Orthopedic Regenerative Surgical Products Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on orthopedic regenerative surgical products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for orthopedic regenerative surgical products ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The orthopedic regenerative surgical products market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Allograft, Synthetic, Cell-based, Viscosupplements
  • 2) By Application: Orthopedic Pain Management, Trauma Repair, Cartilage and Tendon Repair, Joint Reconstruction
  • 3) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
  • Subsegments:
  • 1) By Allograft: Bone Allograft; Soft Tissue Allograft; Osteoinductive Allograft; Osteoconductive Allograft
  • 2) By Synthetic: Synthetic Bone Grafts; Synthetic Soft Tissue Grafts; Composite Synthetic Grafts
  • 3) By Cell-based: Stem Cell Therapies; Platelet-Rich Plasma (PRP); Mesenchymal Stem Cells (MSCs)
  • 4) By Viscosupplements: Hyaluronic Acid Injections; Sodium Hyaluronate; Other Viscosupplement Products
  • Companies Mentioned: Baxter International Inc.; Zimmer Biomet Holdings Inc.; Stryker Corporation; Smith&Nephew plc; Allosource; Anika Therapeutics Inc.; Vericel Corporation; Amniox Medical Inc.; MIMEDX Group Inc.; Aptissen S.A; Arthrex Inc.; Bioventus LLC; Conmed Corporation; DePuy Synthes Inc.; Exactech Inc.; Globus Medical Inc.; Integra LifeSciences Corporation; Johnson & Johnson Medical Devices group; Kuros Biosciences AG; Medtronic plc; NuVasive Inc.; Orthofix Medical Inc.; Osiris Therapeutics Inc.; RTI Surgical Inc.; SeaSpine Holdings Corporation; Terumo BCT Inc.; Tissue Regenix Group plc; Wright Medical Group N.V.; Xtant Medical Holdings Inc.; Camber Spine Technologies; Lima Corporate; Life Spine Inc.; CollPlant Biotechnologies Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Orthopedic Regenerative Surgical Products Market Characteristics

3. Orthopedic Regenerative Surgical Products Market Trends And Strategies

4. Orthopedic Regenerative Surgical Products Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Orthopedic Regenerative Surgical Products Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Orthopedic Regenerative Surgical Products PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Orthopedic Regenerative Surgical Products Market Growth Rate Analysis
  • 5.4. Global Orthopedic Regenerative Surgical Products Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Orthopedic Regenerative Surgical Products Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Orthopedic Regenerative Surgical Products Total Addressable Market (TAM)

6. Orthopedic Regenerative Surgical Products Market Segmentation

  • 6.1. Global Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Allograft
  • Synthetic
  • Cell-based
  • Viscosupplements
  • 6.2. Global Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Orthopedic Pain Management
  • Trauma Repair
  • Cartilage and Tendon Repair
  • Joint Reconstruction
  • 6.3. Global Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Users
  • 6.4. Global Orthopedic Regenerative Surgical Products Market, Sub-Segmentation Of Allograft, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bone Allograft
  • Soft Tissue Allograft
  • Osteoinductive Allograft
  • Osteoconductive Allograft
  • 6.5. Global Orthopedic Regenerative Surgical Products Market, Sub-Segmentation Of Synthetic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Synthetic Bone Grafts
  • Synthetic Soft Tissue Grafts
  • Composite Synthetic Grafts
  • 6.6. Global Orthopedic Regenerative Surgical Products Market, Sub-Segmentation Of Cell-based, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stem Cell Therapies
  • Platelet-Rich Plasma (PRP)
  • Mesenchymal Stem Cells (MSCs)
  • 6.7. Global Orthopedic Regenerative Surgical Products Market, Sub-Segmentation Of Viscosupplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hyaluronic Acid Injections
  • Sodium Hyaluronate
  • Other Viscosupplement Products

7. Orthopedic Regenerative Surgical Products Market Regional And Country Analysis

  • 7.1. Global Orthopedic Regenerative Surgical Products Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Orthopedic Regenerative Surgical Products Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Orthopedic Regenerative Surgical Products Market

  • 8.1. Asia-Pacific Orthopedic Regenerative Surgical Products Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Orthopedic Regenerative Surgical Products Market

  • 9.1. China Orthopedic Regenerative Surgical Products Market Overview
  • 9.2. China Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Orthopedic Regenerative Surgical Products Market

  • 10.1. India Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Orthopedic Regenerative Surgical Products Market

  • 11.1. Japan Orthopedic Regenerative Surgical Products Market Overview
  • 11.2. Japan Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Orthopedic Regenerative Surgical Products Market

  • 12.1. Australia Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Orthopedic Regenerative Surgical Products Market

  • 13.1. Indonesia Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Orthopedic Regenerative Surgical Products Market

  • 14.1. South Korea Orthopedic Regenerative Surgical Products Market Overview
  • 14.2. South Korea Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Orthopedic Regenerative Surgical Products Market

  • 15.1. Western Europe Orthopedic Regenerative Surgical Products Market Overview
  • 15.2. Western Europe Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Orthopedic Regenerative Surgical Products Market

  • 16.1. UK Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Orthopedic Regenerative Surgical Products Market

  • 17.1. Germany Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Orthopedic Regenerative Surgical Products Market

  • 18.1. France Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Orthopedic Regenerative Surgical Products Market

  • 19.1. Italy Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Orthopedic Regenerative Surgical Products Market

  • 20.1. Spain Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Orthopedic Regenerative Surgical Products Market

  • 21.1. Eastern Europe Orthopedic Regenerative Surgical Products Market Overview
  • 21.2. Eastern Europe Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Orthopedic Regenerative Surgical Products Market

  • 22.1. Russia Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Orthopedic Regenerative Surgical Products Market

  • 23.1. North America Orthopedic Regenerative Surgical Products Market Overview
  • 23.2. North America Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Orthopedic Regenerative Surgical Products Market

  • 24.1. USA Orthopedic Regenerative Surgical Products Market Overview
  • 24.2. USA Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Orthopedic Regenerative Surgical Products Market

  • 25.1. Canada Orthopedic Regenerative Surgical Products Market Overview
  • 25.2. Canada Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Orthopedic Regenerative Surgical Products Market

  • 26.1. South America Orthopedic Regenerative Surgical Products Market Overview
  • 26.2. South America Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Orthopedic Regenerative Surgical Products Market

  • 27.1. Brazil Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Orthopedic Regenerative Surgical Products Market

  • 28.1. Middle East Orthopedic Regenerative Surgical Products Market Overview
  • 28.2. Middle East Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Orthopedic Regenerative Surgical Products Market

  • 29.1. Africa Orthopedic Regenerative Surgical Products Market Overview
  • 29.2. Africa Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Orthopedic Regenerative Surgical Products Market Competitive Landscape And Company Profiles

  • 30.1. Orthopedic Regenerative Surgical Products Market Competitive Landscape
  • 30.2. Orthopedic Regenerative Surgical Products Market Company Profiles
    • 30.2.1. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Smith & Nephew plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Allosource Overview, Products and Services, Strategy and Financial Analysis

31. Orthopedic Regenerative Surgical Products Market Other Major And Innovative Companies

  • 31.1. Anika Therapeutics Inc.
  • 31.2. Vericel Corporation
  • 31.3. Amniox Medical Inc.
  • 31.4. MIMEDX Group Inc.
  • 31.5. Aptissen S.A.
  • 31.6. Arthrex Inc.
  • 31.7. Bioventus LLC
  • 31.8. Conmed Corporation
  • 31.9. DePuy Synthes Inc.
  • 31.10. Exactech Inc.
  • 31.11. Globus Medical Inc.
  • 31.12. Integra LifeSciences Corporation
  • 31.13. Johnson & Johnson Medical Devices group
  • 31.14. Kuros Biosciences AG
  • 31.15. Medtronic plc

32. Global Orthopedic Regenerative Surgical Products Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Orthopedic Regenerative Surgical Products Market

34. Recent Developments In The Orthopedic Regenerative Surgical Products Market

35. Orthopedic Regenerative Surgical Products Market High Potential Countries, Segments and Strategies

  • 35.1 Orthopedic Regenerative Surgical Products Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Orthopedic Regenerative Surgical Products Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Orthopedic Regenerative Surgical Products Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer